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Abstract
The intestinal pathogen Clostridioides difficile exhibits heterogeneity in motility and toxin
production. This phenotypic heterogeneity is achieved through phase variation by site-spe-
cific recombination via the DNA recombinase RecV, which reversibly inverts the “flagellar
switch” upstream of the flgB operon. A recV mutation prevents flagellar switch inversion and
results in phenotypically locked strains. The orientation of the flagellar switch influences
expression of the flgB operon post-transcription initiation, but the specific molecular mecha-
nism is unknown. Here, we report the isolation and characterization of spontaneous sup-
pressor mutants in the non-motile, non-toxigenic recV flg OFF background that regained
motility and toxin production. The restored phenotypes corresponded with increased
expression of flagellum and toxin genes. The motile suppressor mutants contained single-
nucleotide polymorphisms (SNPs) in rho, which encodes the bacterial transcription termina-
tor Rho factor. Analyses using transcriptional reporters indicate that Rho contributes to het-
erogeneity in flagellar gene expression by preferentially terminating transcription of flg OFF
mRNA within the 5’ leader sequence. Additionally, Rho is important for initial colonization of
the intestine in a mouse model of infection, which may in part be due to the sporulation and
growth defects observed in the rho mutants. Together these data implicate Rho factor as a
regulator of gene expression affecting phase variation of important virulence factors of C.
difficile.
Author summary
Phenotypic heterogeneity maintained by phase variation allows bacterial subpopulations
to overcome potentially detrimental stresses in the environment, contributing to bacterial
survival. Phase variation of flagella and toxins in C. difficile suggests that maintaining het-
erogeneity of their production may be important for survival and virulence. In this study,
we identified Rho as a trans-acting factor that mediates the differential gene expression
that imparts heterogeneity in flagellum and toxin production. These results reveal a new
role for Rho-mediated transcription termination in regulation of gene expression.
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Introduction
Clostridioides difficile is a gram-positive, spore-forming anaerobe and the leading cause of anti-
biotic-associated diarrheal disease [1]. C. difficile infections (CDI) are currently among the
most common hospital-acquired infections and exhibit a high rate of recurrence [2]. Disease is
largely mediated by two large glucosylating exotoxins, TcdA and TcdB [3–5]. These toxins
inactivate members of the Rho family of GTPases, causing a loss of interaction between the
GTPase and its downstream effectors including those controlling the integrity of the actin
cytoskeleton [6, 7]. In cell culture, toxin activity results in disruption of tight junctions, cell
rounding, and eventually cell death [8, 9]. During infection of a host intestine, the toxins cause
disruption of the epithelial barrier, leading to development of diarrheal symptoms, immune
cell recruitment, and inflammation [10]. These toxins are also necessary for development of
diarrheal disease in animal models of infection [4, 11, 12].
C. difficile encodes multiple surface appendages that contribute to cell adherence and/or
colonization of the intestine, including fibronectin-binding protein Fbp68, type IV pili, and
flagella [13–17]. Flagella are required for swimming motility and are also important for adher-
ence to intestinal epithelial cells, colonization, and virulence in animal models of infection
[18–20]. Similar to Bacillus subtilis and numerous gram-negative bacteria, the flagellar genes
are expressed in a hierarchical manner to ensure the coordinated assembly of the complex
structure [21–23]. C. difficile contains flagellar genes in at least four operons [24]. The early
stage (flgB) flagellar operon includes the gene encoding SigD, a sigma factor essential for
expression of late stage flagellar genes [23, 25, 26]. SigD also positively regulates the expression
of toxin genes by activating transcription of tcdR, which encodes a positive regulator of tcdA
and tcdB expression [23, 27]. Accordingly, factors that regulate expression of the flgB operon,
such as cyclic diguanylate, impact toxin production via SigD [22, 25]. Other regulators, includ-
ing Agr, SinR, and RstA, also affect both flagellum and toxin gene expression [28–32]. For
example, SinR activates both flagellar and toxin gene expression [29, 30], while RstA acts as a
negative regulator of both flagellum and toxin genes [31, 32].
We recently demonstrated the phase variation of flagella and toxins in multiple C. difficile
ribotypes [33, 34]. Phase variation is a process that generates phenotypic heterogeneity in a
bacterial population to help ensure the survival of the population as a whole in response to
environmental selective pressures [35]. Typically, phase variation modulates the production of
surface structures that directly interface with the bacterium’s environment. Several mucosal
pathogens use phase variation to promote immune evasion and persistence in the host [36].
Phase variation occurs stochastically and is also fully reversible to maintain heterogeneity [35].
Multiple genetic and epigenetic mechanisms can lead to phase variation. One mechanisms is
conservative site-specific DNA recombination, which involves recombinase-mediated inver-
sion of a specific DNA sequence [37]. The invertible sequence typically contains regulatory
information, such as a promoter element, that affects downstream gene expression [38]. DNA
inversion requires the action of one or multiple serine or tyrosine recombinases that recognize
inverted repeats flanking the invertible genetic sequence and catalyze DNA strand exchange
that results in inversion of the intervening sequence [37, 39].
Recent work suggests that C. difficile employs recombination-mediated phase variation to
generate an extensive degree of phenotypic heterogeneity. The first biologically characterized
example of phase variation involved the cell wall protein V (CwpV) [40, 41]. Two additional
potential DNA inversions were identified upstream of genes involved in cyclic diguanylate
metabolism [42]. Most recently, high-throughput sequencing was used to identify a total of
seven invertible sequences flanked by inverted repeats in the C. difficileNAP1/B1/027 ribotype
strain R20291, and an eighth in several 017 ribotype strains [43, 44]. The identified sequences
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were shown to undergo inversion, and the sequence upstream of the cmrRST operon was con-
firmed to regulate expression of the downstream genes in a manner consistent with phase vari-
ation [44, 45]. We subsequently showed that site-specific recombination also mediates phase
variation of flagella and toxins by inversion of a genetic sequence called the “flagellar switch”
[33]. The 154 bp flagellar switch is flanked by imperfect inverted repeats and is located
upstream of the flgB operon. In one orientation, the flagellar switch is permissive for expres-
sion of the flgB operon, resulting in “flgON” bacteria exhibiting flagellum biosynthesis, swim-
ming motility, and toxin production. Conversely, the inverse orientation reduces flgB operon
transcription, yielding “flgOFF” bacteria that are aflagellate, non-motile, and attenuated for
toxin production. Inversion of the flagellar switch requires the site-specific tyrosine recombi-
nase RecV. Mutation of recV leads to genotypically and phenotypically “phase locked” strains
that no longer undergo phase variation [33]. In contrast to these phase locked mutants, wild-
type C. difficile R20291 in broth culture consists of a heterogeneous population of flgON and
OFF bacteria. Notably, RecV is also required for inversion of the cwpV switch, as well as two of
the other identified invertible sequences including one shown to impact multiple phenotypes
including virulence [40, 44, 45].
The canonical regulatory mechanism of phase variation by site-specific recombination
involves an invertible promoter element that, when correctly oriented, promotes gene tran-
scription in cis. For example, production of fimbriae by Escherichia coli and related species is
regulated by the invertible fimbrial switch fimS, which contains a promoter for the adjacent
fimA gene that encodes the fimbrial subunit [46, 47]. The flagellar switch in C. difficile lies in
the 5’ untranslated region of the mRNA, between the previously identified σA-dependent pro-
moter and the flgB coding sequence. Previous work showed that the flagellar switch does not
contain a functional promoter [33]. Instead, regulation occurs post-transcription initiation
and involves an unidentified trans-acting posttranscriptional regulator specific to C. difficile.
In this study, we sought to identify the mechanism by which the flagellar switch controls
expression of flagellum and toxin genes. Specifically, how does the orientation of the flagellar
switch mediate the phase variable expression of the flgB operon? To answer this question, we
used a non-motile recV phase-locked OFF strain in a suppressor analysis to identify factor(s)
involved in inhibiting flgB operon transcription, swimming motility, and virulence character-
istics. We recovered suppressor mutants that retained the flagellar switch in the OFF orienta-
tion but gained extragenic mutations that restored swimming motility, toxin production, and
expression of flagellum and toxin genes. The extragenic mutations conferring the suppressor
phenotypes mapped to rho, which encodes the transcription termination factor Rho. Using a
series of reporter fusions in C. difficile with or without an intact rho allele, we determined that
Rho inhibits transcription from the 5’ leader sequence of flgBmRNA with the flagellar switch
in the OFF orientation but not the ON orientation. These results suggest that Rho can discrim-
inate between flgON and flgOFF mRNA to selectively inhibit transcription in flagellar phase
OFF variants, and reveal a role for Rho-mediated transcription termination phase variation of
C. difficile flagella and toxins. Further phenotypic characterization of rhomutants additionally
linked the loss of Rho to altered sporulation and ability to colonize the intestine in a murine
model of infection, indicating a broader role for Rho-mediated transcription termination in C.
difficile physiology.
Results
Motile suppressors arise from a non-motile recV flg OFF mutant
In C. difficile strain R20291 (ribotype 027), the DNA recombinase RecV is required for flagellar
switch inversion, and loss of recV leads to phenotypically-locked bacteria [33]. These recV
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locked ON (recV flgON, RT1702) and locked OFF (recV flgOFF, RT1693) strains are pheno-
typically distinct. As previously shown, recV flgON bacteria are motile in soft agar, while recV
flgOFF bacteria typically remain non-motile even after 72 hours (Fig 1A); in a subset of experi-
ments, we observed spreading of the recV flgOFF mutant after prolonged incubation in soft
agar (�72 hours) (Fig 1A, right panel) [33]. In contrast to the uniform motility exhibited by
WT and recV flgON bacteria, these ‘motile flares’ were irregular and asymmetrical. The same
phenomenon was observed for an independent recV flgOFF mutant, RT1694, which differs
from RT1693 in the orientation of the invertible sequence upstream of cwpV, another phase
variable locus (S1 Fig) [33, 48]. To recover the motile bacteria, which we term motile suppres-
sors (MS) hereafter, we collected growth from the outer edge of the motile flares and subcul-
tured on BHIS agar to obtain isolated colonies. When inoculated into soft agar, these MS
showed motility similar to that of WT bacteria; an example is shown in Fig 1B. A total of 14
MS isolated from RT1693 and RT1694 were assayed for swimming motility in soft agar. All 14
MS regained swimming motility to the level of the recV flgON strain, while the recV flgOFF
and non-motile sigD-null control remained non-motile (S2 Fig); the results for 6 representa-
tive MS are shown in Fig 1C. Consistent with these phenotypes, production of the flagellin
FliC was restored in these 6 representative MS, with FliC levels equivalent to or higher than
recV flgON (Fig 1D). FliC was undetectable in the recV flgOFF parental strain.
This observation suggested that the recV flgOFF mutant is capable of recovering motility.
One possible explanation is that a recombinase other than recV catalyzed inversion of the fla-
gellar switch. To test this possibility, we used orientation-specific polymerase chain reaction
(OS-PCR), which employs primer pairs that specifically amplify one orientation of an invert-
ible sequence or the other (S1 Table) [33]. Wild-type C. difficile R20291 grown in BHIS broth
consists of a heterogeneous population. Accordingly, both OFF and ON flagellar switch orien-
tations were detected by OS-PCR (Fig 1E). As determined previously, the recV flgOFF and
recV flgON strains yielded 280bp and 375bp product sizes, respectively, which correspond to
the known flagellar switch orientations in these mutants [33]. The 14 MS contained the flagel-
lar switch exclusively in the OFF orientation, with a representative 6 MS shown in Fig 1D.
These results indicate that flagellar switch inversion did not occur, and the MS retain the flg
OFF genotype despite their motile phenotype (Fig 1B). We also sequenced the promoter
region and 5’ UTR of the flgB operon and did not find any mutations in the MS compared to
the parental strains. Together, these results suggest that additional mechanisms are involved in
inhibiting motility in C. difficile when the flagellar switch is in the OFF orientation.
Identification of Rho as a negative regulator of flagellar motility
Soft agar swimming motility assays provide a strong selective pressure for bacterial self-propul-
sion to enable access to nutrients as they become depleted locally. The results above suggest
that extragenic mutations arose in the MS that alleviated the negative effect of the flgOFF
genotype on swimming motility in this assay. We postulated that a suppressor mutation
occurred in a gene(s) involved in inhibiting flagellar gene expression in recV flgOFF bacteria.
We thus performed whole genome sequencing of seven motile suppressors (MS 1–7) to iden-
tify single nucleotide polymorphisms (SNPs) compared to the R20291 wild type reference
genome (detailed in S2 Table, S1 Data). Compared to the recV flgOFF strain, five of seven MS
carried SNPs upstream of CDR20291_1465, which encodes a putative Mn2+-containing cata-
lase. The same five MS (MS 2–6) also carried SNPs in the region between CDR20291_1414
and 1415, which are convergently transcribed and encode the putative acetolactate synthase
subunit IlvB and a phage-associated integrase, respectively. Additional SNPs appeared within
the inverted repeats of switches upstream of cwpV and the flgB operon, in accordance with
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Fig 1. Motile suppressor mutants arise from a non-motile recV flg OFF strain. (A) Swimming motility in soft agar medium of C.
difficile R20291 (WT), recV flgON (RT1702), recV flgOFF (RT1693), and sigD-null non-motile control. Images were taken of
representative plates after 24, 48 and 72 h. The arrow on the 72 h image points to a motile flare arising from recV flgOFF. (B) Swimming
motility in soft agar medium of C. difficile R20291 (WT), recV flgOFF (RT1694), MS5, and sigD-null non-motile control. Image of a
representative plate at 48 h. (C) Quantification of swimming motility of 6 motile suppressors (MS) selected for further characterization.
Swim diameter was measured after 48 h. The means and standard deviation from 4 biological replicates are shown. ����p<0.0001 by
one-way ANOVA and Dunnett’s post-test compared to recV flgOFF. (D) Immunoblot detection of FliC in recV flgON and OFF and
select MS. Shown is a representative image of three independent experiments. Numbers represent quantification of band intensity
expressed as fold-change relative to recV flgON. ND–non-detectable. (E) Orientation-specific PCR for flagellar switch in six motile
suppressors, WT, and recV flgON and OFF controls. Band sizes– 280bp (OFF) or 375bp (ON). Shown is a representative image of three
independent experiments.
https://doi.org/10.1371/journal.ppat.1008708.g001
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these strains containing inversions in the cwpV and flg switches relative to the R20291 refer-
ence genome. Similarly, SNPs were also present in the inverted repeats flanking the invertible
sequence upstream of CDR20291_0685, which was previously shown to be heterogeneous
compared to the R20291 reference [44, 45].
A single locus, CDR20291_3324, contained SNPs in MS 1–7 compared to the allele in R20291
(Table 1, S1 Data); SNPs in this gene did not appear in either recV flgOFF parent. These SNPs
showed a high frequency (89% or greater) in the sequencing reads. In lieu of whole genome
sequencing, we Sanger sequenced CDR20291_3324 in MS 8–14 and identified additional SNPs in
all of them. CDR20291_3324 encodes Rho factor, a transcriptional terminator known to act at the
3’ ends of genes or operons as an alternative mechanism to the use of an intrinsic terminator [49].
Rho binds nascent transcripts at Rho utilization (rut) sites, cytosine-rich sequences with poor con-
sensus [49]. Hexameric Rho then uses ATPase activity to translocate 5’ to 3’ along the RNA.
Although the mechanism of Rho-dependent transcription termination is not fully understood, it
is thought to occur when Rho reaches the RNA polymerase, e.g. at an RNAP pause site, and forces
its movement on template DNA without nucleotide addition, leading to destabilization of the
transcription complex and mRNA release [50]. The SNPs identified in rhomapped to different
domains of the Rho protein, including an N-terminal insertion domain (NID), primary binding
site (PBS), and the C-terminal ATPase domain (Fig 2A). Mutations included substitutions (e.g.
R206I, G284E) as well as nonsense mutations resulting either from a SNP creating a stop codon
(e.g. E113-Stop) or a frameshift (e.g. N66-FS, resulting in a stop codon at residue 73).
Rho is essential for viability in gram-negative bacteria but dispensable in gram-positive bac-
teria studied to date, such as Bacillus subtilis and Staphylococcus aureus [51, 52]. Based on a
transposon mutagenesis screen, Rho is not essential for viability in C. difficile [53]. However,
loss of Rho can cause growth defects potentially due to inappropriate, pervasive read-through
transcription [54–56]. Therefore, we assessed the growth of the 14 motile suppressors in BHIS
broth. All motile suppressors reached a lower final optical density (OD600) compared to recV
flgOFF (S3 Fig). While doubling times during exponential growth for the recV flgON and
Table 1. Summary of single nucleotide polymorphisms in recV flg OFF motile suppressor mutants.
recV flg OFF Suppressor Position on Chromosomea Nucleotide Locus Tag Gene Amino Acid Change
Ref Alt Freqb Coverb
MS1 3955138 T C 99.28 978 3324 rho N533S
MS2 3955300 C A 99.13 2295 3324 rho G479V
MS3 3955885 C T 97.66 2055 3324 rho G284E
MS4 3955391 C A 99.05 2114 3324 rho E449-Stop
MS5 3956539 T / 89.83 2056 3324 rho N66-FS
MS6 3955955 C A 99.22 2055 3324 rho E261-Stop
MS7 3956119 C A 99.02 2447 3324 rho R206I
MS8 1433 C T N/A N/A 3324 rho S478F
MS9 1226 T C N/A N/A 3324 rho L409P
MS10 337 G T N/A N/A 3324 rho E113-Stop
MS11 1598 A G N/A N/A 3324 rho N533S
MS12 980 G T N/A N/A 3324 rho R327I
MS13 973 G A N/A N/A 3324 rho D325N
MS14 754 G A N/A N/A 3324 rho E252-Stop
a Note that rho is encoded on the complementary strand, and reference and alternate (Ref/Alt) nucleotides are designated based on chromosome position for MS#1–7
and gene position, i.e. sense orientation, for MS#8–14.
b Frequency of the alternate nucleotide and coverage of reads at each of the indicated positions.
https://doi.org/10.1371/journal.ppat.1008708.t001
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OFF strains were 56.5 ± 6.0 and 63.6 ± 3.5, respectively, growth rates for the MS ranged from
71.8 to 129.9 minutes, and 10 of the MS showed significant attenuation of doubling time
(Table 2).
Fig 2. Rho is a negative regulator of flagellar motility. (A) Diagram of Rho factor domains and single nucleotide polymorphisms
(SNPs) identified in the motile suppressors (MS). NHB–N-terminal helix bundle, NID–N-terminal insertion domain, PBS–primary
binding site, FS–frameshift, St–stop codon. N66-FS results in a stop codon at residue 73. (B) Swimming motility in soft agar medium of
motile suppressor 5 (MS5; N66-FS) and 10 (MS10; E113-St) expressing wild-type rho (pRho) or bearing vector at 48 hours. Controls
included recV flgON, recV flgOFF and non-motile sigDmutant carrying vector. (C) Quantification of swimming motility after 48 h of
strains in (B). The means and standard deviation from 3 independent experiments are shown. ����p<0.0001, �p<0.05 by one-way
ANOVA and Tukey’s post-test. (D) Immunoblot detection of FliC by strains in (B, C). Shown is a representative image of three
independent experiments. Numbers represent quantification of band intensity expressed as the fold change compared to recV flgON for
the image shown. ND–non-detectable. (E) Relative transcript abundance of flgB and fliCmeasured by qRT-PCR. The means and
standard deviation from 4 biological replicates are shown. ��p<0.01, �p<0.05 by one-way ANOVA and Dunnett’s post-test compared to
recV flgOFF.
https://doi.org/10.1371/journal.ppat.1008708.g002
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Because the rhomutations restored motility to the recV flgOFF mutants, we next tested the
effect of expressing the wild-type rho allele in rho-null strains. We were unsuccessful in generat-
ing an in-frame deletion of rho, likely because of the associated growth defects. In lieu of a tar-
geted mutant, we utilized MS5 and MS10, which contain stop codons early in the rho coding
sequence: N66-FS (stop codon at position 73) and E113-St, respectively (Fig 2A). A plasmid car-
rying wild-type rho under control of an inducible promoter, pRho, was introduced into these
MS, and the resulting strains were assayed for swimming motility. The vector control strains
showed the expected swimming motility behaviors after 48 hours (Fig 2B and 2C). Expression of
rho in MS5 and MS10 significantly inhibited swimming motility compared to the respective vec-
tor controls, effectively complementing the effects of the SNPs in rho. Consistent with these phe-
notypes, expression of rho led to 3- to 4-fold decreases in FliC levels in MS5 and MS10 compared
to vector controls (Fig 2D). To examine whether changes in protein production and swimming
were due to changes in flagellar gene transcription, we used quantitative reverse transcriptase
PCR (qRT-PCR) to measure the transcript abundance of flgB, the first gene of the operon con-
trolled by the flagellar switch, and fliC, which encodes flagellin and is regulated by SigD [22, 25].
The flgB transcript abundance was higher in MS5 and MS10 than recV flgOFF, though the differ-
ences were not significant (Fig 2E, left). Both MS5 and MS10 had significantly increased fliC tran-
script levels compared to recV flgOFF (Fig 2E, right). Providing rho in trans reduced flgB and fliC
transcript abundance compared to the vector control. Notably, expression of rho also corrected
the growth defect of MS5 and MS10 to the level of recV flgOFF parent with vector (S4 Fig).
Together these results indicate that Rho regulates flagellum production and swimming motility
in C. difficile by directly or indirectly inhibiting transcription of flagellar genes.
Rho inhibits heterogeneous flagellar gene expression
Analysis of flagellar gene expression by qRT-PCR reflects the transcript abundance averaged
across the bacterial population. Yet, phase variation generates a heterogeneous population of
Table 2. Doubling times in rich medium.
Strain Doubling Time (min)a, b
recV flg ON 56.5 ± 6.0
recV flg OFF 63.6 ± 3.5
MS1 75.7 ± 6.6
MS2 129.9 ± 12.2
MS3 98.0 ± 10.5
MS4 122.2 ± 10.5
MS5 123.1 ± 27.8
MS6 126.1 ± 27.8
MS7 75.9 ± 4.6
MS8 71.8 ± 5.5
MS9 98.2 ± 3.5
MS10 91.0 ± 3.3
MS11 76.0 ± 4.5
MS12 103.5 ± 3.4
MS13 85.1 ± 1.5
MS14 97.0 ± 4.7
a Means and standard deviations for data from two experiments each with 3 biological replicates (n = 6).
b Bold indicates p < 0.05 by one-way ANOVA and Dunnett’s post-test compared to recV flg OFF.
https://doi.org/10.1371/journal.ppat.1008708.t002
PLOS PATHOGENS Rho factor mediated phase variation
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1008708 August 12, 2020 8 / 28
bacteria, some of which express flagellar genes, and some of which do not. To analyze the
effects of Rho on flagellar gene expression at the single cell level, we used fluorescence micros-
copy with a red fluorescence protein (mCherryOpt) reporter gene under the control of the
flgM promoter (PflgM), which is a SigD-dependent promoter in the late stage flagellar operon
[22, 23]. Expression of mCherryOpt from the flgM promoter is thus an indirect indication of
the flagellar switch orientation. As previously observed, a population of wild-type C. difficile
R20291 exhibited heterogeneity in fluorescence, with the majority of cells expressing mCher-
ryOpt (Fig 3) [33]. In contrast, virtually no red cells were detectable for recV flgOFF C. difficile.
Heterogeneous fluorescence was restored in MS5 and MS10 carrying PflgM::mCherryOpt (Fig
3). Thus, Rho is necessary for suppression of flagellar gene expression in recV flgOFF bacteria.
Rho negatively impacts toxin production
The alternative sigma factor SigD, encoded in the flgB operon, positively regulates the expres-
sion of tcdR, tcdA, and tcdB [23, 27]. We therefore predicted that inhibition of flgB operon
Fig 3. Rho inhibits heterogeneous flagellar gene expression in a recV flg OFF background. Micrographs of C.
difficile R20291 (WT), MS5 and its recV flgOFF cwpVON parent (RT1694), and MS10 and its recV flgOFF cwpVOFF
parent (RT1693) transformed with the pPflgM::mCherryOpt reporter plasmid. Representative images for three
independent experiments. Channels used are indicated for each column. White bars = 10 microns.
https://doi.org/10.1371/journal.ppat.1008708.g003
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transcription by Rho would concomitantly inhibit toxin gene expression. We evaluated TcdA
production in MS5 and MS10 carrying vector or pRho by immunoblot. MS5 and MS10 showed
a 3- to 4-fold increase in TcdA production, respectively, compared to the recV flgOFF parent
(Fig 4A). Expression of wild-type rho in MS5 and MS10 decreased TcdA levels, resulting in
TcdA levels comparable to recV flgOFF bacteria. To determine whether changes in protein lev-
els correlate with changes in transcript abundance, we examined expression of tcdR, tcdA, and
tcdB by qRT-PCR. As observed previously, tcdA and tcdB transcript abundance was signifi-
cantly higher in recV flgON than recV flgOFF bacteria; tcdR was similarly altered, though the
difference was not statistically significant (Fig 4B) [33]. Consistent with the negative impact of
Rho on flagellar gene expression, tcdA, tcdB, and tcdR transcript levels were higher in MS5 and
MS10 than in the recV flgOFF parent (Fig 4B). Providing rho in trans decreased tcdA, tcdB, and
tcdR transcript abundances of MS5 and MS10 to the parental recV flgOFF levels. Therefore, in
addition to inhibiting motility and growth, Rho negatively affects toxin gene expression and
production. This effect is likely mediated through SigD encoded in the flgB operon [23, 27].
Mutant rho alleles confer dominant negative motility phenotypes
Rho factor functions as a homohexamer [57]. We hypothesized that overexpression of mutant
rho alleles could result in incorporation of aberrant subunits into the hexamer, interfering
Fig 4. Mutations in rho impact toxin production. (A) Immunoblot detection of TcdA by MS5 and MS10 bearing pRho
for expression of wild-type rho or bearing vector. Controls included recV flgON, recV flgOFF and sigDmutant carrying
vector. Shown is a representative image for three independent experiments. Numbers represent quantification of band
intensity expressed as the fold change compared to recV flgON for the image shown. (B) Relative transcript abundance of
tcdA, tcdB, and tcdRmeasured by qRT-PCR. The means and standard deviation from 3 to 5 biological replicates per strain
are shown. ����p<0.0001, ���p<0.001, ��p<0.01, �p<0.05 by one-way ANOVA and Dunnett’s post-test compared to recV
flgOFF.
https://doi.org/10.1371/journal.ppat.1008708.g004
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with Rho function. To test for this dominant negative effect, we introduced mutant rho alleles
from six different MS into the recV flgOFF strain, with the expectation that incorporation of
non-functional Rho monomers would prevent inhibition of swimming motility by the wild-
type, chromosomally-encoded Rho. The wild-type rho allele was also introduced as a control.
To achieve overexpression of the cloned alleles, the genes were placed under the control of an
anhydrotetracycline (ATc)-inducible promoter in the multi-copy plasmid pRPF185. Strains
bearing these expression plasmids were assayed for swimming motility in soft agar medium.
Expression of five of the six of the mutant rho alleles restored swimming motility to varying
extents, while the wild-type allele did not alter motility (Fig 5A and 5B). These results were
obtained regardless of ATc induction, suggesting leaky expression from the Ptet promoter as
previously reported [58, 59]. The only mutant allele that did not lead to a dominant negative
motility phenotype was N66-FS derived from MS5 (Fig 2A). Because this rho allele contains a
nonsense mutation resulting in an early stop codon at residue 73, the truncated gene product
may be unstable or unable to incorporate into the Rho hexamer, further justifying the use of
the MS5 strain as a rho-null mutant.
Rho preferentially inhibits transcription of flg OFF mRNA
Our prior work suggests that transcription termination of flgOFF bacteria is mediated by a
trans-acting factor specific to C. difficile [33]. This role could be fulfilled by Rho. While Rho
typically terminates transcription of genes and operons 3’ of coding sequences, recent studies
have shown that Rho can also terminate transcription in some 5’ leader regions in gram-nega-
tive bacteria [60–63]. This mechanism would have a regulatory effect on the downstream gene
(s). We therefore hypothesized that Rho is this trans-acting factor affecting transcription of the
flgB operon, preferentially inhibiting transcription in flgB transcripts containing the flagellar
switch in the OFF orientation. To test this hypothesis, we transcriptionally fused a phoZ
reporter gene to the flgB coding sequence and the upstream regulatory region of the flgB
operon. This 1045 bp region includes the σA-dependent promoter and the 498 bp 5’ untrans-
lated region containing with the flagellar switch in either the ON or OFF orientation: PflgB-
UTRON::phoZ and PflgB-UTROFF::phoZ respectively. Promoterless (::phoZ) and promoter-only
Fig 5. Mutant rho alleles confer dominant negative motility phenotypes. (A) Swimming motility in soft agar medium after 72 hours
for the recV flgOFF (RT1693) expressing rho alleles encoding the indicated Rho proteins. Labels correspond to SNPs in rho (Fig 2A),
and WT corresponds to the wild-type rho allele. Dominant negative effects are present regardless of anhydrotetracycline (ATc)
induction suggesting leaky expression from the Ptet promoter. (B) Quantification of swim diameter from soft agar plates containing
15ng/mL ATc after 72 hours. The means and standard deviation of three biological replicates are shown. ����p<0.0001, ���p<0.001,
��p<0.01 by one-way ANOVA and Dunnett’s post-test compared to recV flgOFF.
https://doi.org/10.1371/journal.ppat.1008708.g005
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constructs (PflgB::phoZ) were included as controls. These plasmid-borne reporters were intro-
duced into recV flgON and OFF strains, which encode wild-type Rho, and MS5 and MS10,
which contain mutant rho alleles, and alkaline phosphatase activity was assayed [64]. As antici-
pated, the no-promoter control lacked activity in all strains, and no differences were observed
for activity of the promoter only reporter suggesting that Rho does not regulate transcription
at the level of promoter (S5 Fig). For the PflgB-UTRON::phoZ reporter, activity was modestly
(~3-fold) higher in MS5 and MS10 compared to the recV flgOFF parent (Fig 6A). In compari-
son, activity was ~15-fold higher in MS5 and MS10 compared to recV flgOFF for the PflgB-
UTROFF::phoZ reporter. Therefore, mutation of rho had a greater effect on flagellar gene tran-
scription for bacteria with the flagellar switch in the OFF orientation, suggesting that Rho pref-
erentially inhibits transcription of the flgOFF transcript.
The results of alkaline phosphatase assays in C. difficile imply that Rho negatively regulates
flgB operon transcription, but do not distinguish between a direct and indirect mechanism of
regulation. Rho could directly act on the flgBUTR to terminate transcription from flgBOFF
mRNA, or Rho could impact the production of another protein involved in flgB regulation.
We previously showed that, whereas the PflgB-UTRON::phoZ reporter resulted in significantly
higher activity than the PflgB-UTROFF::phoZ reporter in C. difficile, the difference was lost when
these reporters were assayed in B. subtilis [33]. These results indicate that B. subtilis does not
encode the factor that mediates regulation. We postulated that if Rho directly terminates tran-
scription within the flgB 5’ UTR, introducing C. difficile rho (Cd-rho) into B. subtilis strains
carrying the PflgB-UTRON::phoZ and PflgB-UTROFF::phoZ reporters would restore the regula-
tion seen in C. difficile. To test this idea, the wild-type Cd-rho allele was introduced into the
previously constructed B. subtilis reporter strains [33], and alkaline phosphatase activity was
assayed. As seen previously, reporter activity was the same in B. subtilis with PflgB-UTRON::
Fig 6. C. difficile Rho directly inhibits flagellar gene expression in flg OFF orientation. (A) Alkaline phosphatase (phoZ) reporter
fusions to the flgB operon regulatory region, with the flagellar switch in either the ON or OFF orientation, were introduced into the recV
flgON (RT1702), recV flgOFF (RT1693), MS5 and MS10 strains. Alkaline phosphatase activity was normalized to the recV flgOFF values.
The means and standard deviation of 5 biological replicates are shown. ����p<0.0001 by two-way ANOVA and Tukey’s post-test. (B) The
C. difficile rho gene was introduced into Bacillus subtilis bearing the phoZ fusions to the flgB regulatory region with the flagellar switch in
either the ON or OFF orientation. C. difficile rho (Cd-rho) was introduced, and alkaline phosphatase activity was assayed. Control–B.
subtilis reporter without Cd-rho; BCM–bicyclomycin, 50 μg/mL. The means and standard deviation of three biological replicates are
shown. ����p<0.0001, �p<0.05 by two-way ANOVA with Sidak’s post-test comparing strains with the same reporter construct.
https://doi.org/10.1371/journal.ppat.1008708.g006
PLOS PATHOGENS Rho factor mediated phase variation
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1008708 August 12, 2020 12 / 28
phoZ and PflgB-UTROFF::phoZ (Fig 6B). Expression of Cd-rho resulted in decreased activity
only in B. subtilis with the PflgB-UTROFF::phoZ reporter. Finally, the addition of bicyclomycin,
a specific inhibitor of Rho ATPase activity [65], abrogated this effect. These data indicate that
Rho, and not another C. difficile protein, is the trans-acting factor which directly inhibits fla-
gellar gene expression, and that Rho selectively prevents transcription in flgOFF bacteria.
Rho is important for early colonization in a mouse model of infection and
efficient sporulation
In vitro, Rho affects several phenotypes including growth, motility, and toxin production.
Because these characteristics are important during CDI, we analyzed the effect of a rhomuta-
tion in a mouse model of infection. MS5 and MS10 were derived from two recVmutant strains
that differ in cwpV status–MS5 was derived from RT1694 (cwpVON) while MS10 was derived
from RT1693 (cwpVOFF) [48]. The role of cwpV in vivo has not been previously reported, so
both recV flgOFF parental strains were tested. RecV is required for site-specific recombination
of multiple invertible sequences, not only the flagellar and cwpV switches [44, 45, 48]. To
ensure appropriate attribution of phenotypes, we confirmed that the parental strains and
motile suppressors are isogenic for the other sequences and only differ in the cwpV switch
(S6A Fig). Male and female C57BL/6 mice were treated with antibiotics to render them suscep-
tible to C. difficile and then inoculated by oral gavage with 105 spores of wild-type R20291,
MS5, MS10, and their respective parent strains.
As observed previously, wild-type R20291 colonized the mice within 1 day post-inoculation
(reaching more than 106 CFU/g feces), maintained this level of colonization for 1–3 days, then
was gradually cleared typically between days 3 and 7 post-inoculation (S6B Fig). A similar, but
not identical pattern of colonization was seen for both recV flgOFF strains, suggesting that
cwpV expression does not consistently impact colonization in this model. For MS5 and MS10,
the bacterial burden in feces was significantly lower on day 1 post-inoculation compared to the
respective recV flgOFF parents and wild-type R20291 (Fig 7A). About 50% of the animals
inoculated with MS5 or MS10 had undetectable levels of C. difficile in their feces; most of the
remaining animals showed intermediate or parental levels of colonization. Interestingly, colo-
nization of both MS5 and MS10 recovered to parental levels starting at day 2 post infection
and were cleared within a similar time frame (S6B Fig), suggesting that Rho is important for
initial colonization in a mouse model of infection. Notably, although the recV flgON, MS5,
and MS10 strains differ in toxin production compared to the recV flgOFF strain in vitro, we
did not observe significant differences in weight loss or diarrheal symptoms between the
groups of infected animals. These results may be attributable to the subclinical colitis caused
by R20291 in this animal model, as previously reported [66–68]. It is also possible that other
regulators of toxin gene expression, such as CodY and CcpA, unlink co-expression of the toxin
and flagellar genes [69–72].
Sporulation and germination are important for colonization of the mouse model [73].
Because both MS5 and MS10 were attenuated for colonization on day 1 of infection, we con-
sidered that this difference is attributable to a germination and/or sporulation defect. We
assessed sporulation and spore viability by enumerating ethanol resistant spores as a percent-
age of total cells (spore plus vegetative) [74]. While the sporulation efficiency for the wild type
and both recV flgOFF strains was between 10 and 15%, sporulation efficiency was<1% for
both motile suppressors (Fig 7B). Our data implicate Rho as an important factor that positively
regulates sporulation, which may contribute to the colonization defect observed in the mouse
model. It is possible that additional SNPs in the motile suppressors also contribute to the spor-
ulation defect.
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To examine germination, purified spores of wild-type R20291, both recV flgOFF strains,
MS5, and MS10 were assayed in buffer supplemented with the spore germinant 10 mM tauro-
cholic acid (TA) as previously described [75]. In the absence of TA, no germination was
detected. In the presence of TA, all strains germinated to the same level, indicating that Rho
does not influence germination rate (S7 Fig).
Discussion
In this study, we identified Rho as a trans-acting factor that controls phase variation of flagella
and toxins in vitro. The regulation exerted by Rho contributes to the ability of a population of
C. difficile to continually maintain motile, toxin-producing flgON cells as well as non-motile,
atoxigenic flgOFF cells. Comparative transcriptional analyses using C. difficile as well as B. sub-
tilis as a heterologous system support that Rho inhibits flagellar gene transcription selectively
in flgOFF bacteria. These results implicate Rho as an important regulatory component medi-
ating phase variation of flagella, and by extension toxins, and reveal a new role for Rho-medi-
ated transcription termination in regulation of gene expression.
All of the 14 motile suppressors (MS) contained nucleotide polymorphisms in Rho confer-
ring a missense or nonsense mutation that presumably abrogated Rho function. Five of six rho
alleles, which correlated with a range of growth defects in the respective MS, led to a dominant
negative effect and relieved inhibition of motility in flgOFF bacteria when over expressed. In
E. coli, a dominant negative effect resulted from less efficient binding of mRNA to the Rho sec-
ondary binding site and decreased translocation of Rho along the mRNA towards RNA poly-
merase [76]. In C. difficile, incorporation of mutant subunits into the Rho homohexamer
could negatively affect mRNA binding, ATP processing and/or resulting helicase activity.
These mechanisms are not mutually exclusive–mutations in different domains of Rho may
affect Rho activity by different mechanisms while imparting the same effect on motility. We
Fig 7. Rho is important for early colonization in a mouse model of infection and efficient sporulation. (A) Antibiotic-treated male
and female C57BL6 mice were inoculated with 105 spores of the indicated C. difficile strain. CFU in feces collected at 24 hours post
inoculation were enumerated. Data are combined from two independent infection studies that each included 3 male and 3 female mice
for 12 total mice per strain. Symbols indicate CFU from individual animals, and bars indicate the medians. ����p<0.0001, �p<0.05 by
Kruskal-Wallis test with Dunn’s post-test comparing motile suppressors to their parent strains: RT1694 (recV flgOFF cwpVON) and
MS5, RT1693 (recV flgOFF cwpVOFF) and MS10. Dotted line represents a limit of detection. (B) Sporulation efficiency was evaluated by
ethanol resistance and calculated as the total number of spores divided by the total number of viable cells (spores plus vegetative). A
sporulation-deficient spo0Amutant was included as a control. The means and standard deviation of four biological replicates are shown.
����p<0.0001 by one-way ANOVA with Tukey’s post-test comparing all strains. n.d.–non-detectable.
https://doi.org/10.1371/journal.ppat.1008708.g007
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note that we were unable to generate an independent mutation in rho in a wild-type R20291
background, however the MS5 and MS10 strains with truncated Rho represent useful mutants
for characterization of rho-null C. difficile. Further studies will determine how the mutant Rho
proteins are altered in function and the mechanism by which mutant rho alleles interfere with
function of wild-type Rho.
Rho suppressor mutants exhibit restored motility compared to the flgOFF bacteria from
which they were derived. The increased motility of motile suppressors corresponds with
increased expression of flagellar genes flgB and fliC and higher levels of the major flagellin
FliC. Furthermore, Rho contributes to heterogeneity of flagellar expression at the single cell
level as evidenced by differences in mCherry signal driven by the SigD-dependent flgM pro-
moter. Unlike the recV flgOFF strain that lacks fluorescence, motile suppressors derived from
flgOFF bacteria are mCherry positive and appear similar to a wild-type population. That loss
of Rho in the MS resulted in heterogenous fluorescence intensity among individual cells indi-
cates that another factor influences expression. A c-di-GMP riboswitch is encoded between
the flgB transcriptional start site and the flagellar switch, and we speculate that fluorescence
intensity reflects varying levels of c-di-GMP [77, 78].
Experiments with transcriptional phoZ fusions in C. difficile and B. subtilis indicate that
Rho strongly inhibits transcription when the flagellar switch is in the OFF orientation. We pro-
pose two alternative models for direct control of phase variable expression of the flgB operon
by Rho through the selective, premature termination of flgOFF transcripts (Fig 8). In model 1,
Rho distinguishes between flgON and OFF mRNA by preferentially binding to flgOFF
mRNA due to the presence of rut sequences that are absent in the flgON. In model 2, Rho
binds flgON and OFF mRNAs equally, 5’ of the flagellar switch. Transcription termination
may then be differentially influenced by the presence of an additional sequence required for
termination. For example, an RNA polymerase pause site may appear only in flgOFF mRNA
[61]. In either model, Rho would selectively terminate flgB operon transcription and inhibit
linked phenotypes in bacteria with the flagellar switch in the OFF orientation. More work is
needed to distinguish between these two models. Using the RhoTermPredict algorithm [79],
we were unable to identify any predicted rut sites within the flgB leader sequence of either flg
ON or OFF sequences. RhoTermPredict is based on E. coli, B. subtilis, and S. enterica databases
and searches for rut sites with regularly spaced C residues and C>G content followed by a
Fig 8. Proposed models of direct Rho binding and inhibition of transcription readthrough of flg OFF mRNA.
Model 1: Rho distinguishes between flgON and OFF mRNA by preferentially binding to flgOFF mRNA. This may be
due to the presence of rut sequences that are absent in the flgON. Model 2: Rho binds flgON and OFF mRNAs
equally, 5’ of the flagellar switch. Transcription termination may then be differentially influenced by the presence of an
additional sequence required for termination (e.g. a RNA polymerase pause site) only in flgOFF mRNA.
https://doi.org/10.1371/journal.ppat.1008708.g008
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putative RNA polymerase pause site [79]. However, the C. difficile genome has low G+C con-
tent (<30%) [80], and the flgB leader sequence has 23% G+C content. The rut site characteris-
tics in C. difficile therefore may be different from those previously described in other bacteria,
so the RhoTermPredict algorithm may be unsuitable for predicting rut sites in C. difficile.
There are several examples of Rho exerting regulation on 5’ leader sequences in gram-nega-
tive bacteria, where gene regulation by Rho is achieved by multiple mechanisms involving
other proteins, small RNAs, and potentially yet unidentified factors. In E. coli, Rho seems to
preferentially regulate expression of>250 genes with long 5’ UTRs [81]. In addition, the
RNA-binding protein CsrA binds to the 5’ UTR of pgaA to prevent the formation of an RNA
secondary structure that otherwise sequesters the rut site [82]. In S. enterica serovar Typhimur-
ium, Rho binds within the leader sequences of three genes encoding Mg2+ transporters to con-
trol expression [60, 62, 83], and the small RNA ChiX inhibits expression of the chiPQ operon
by inducing premature Rho-dependent termination [84]. Finally, most known E. coli ribos-
witches modulate gene expression by either translational regulation or Rho-dependent termi-
nation [60, 85]. However, riboswitches in C. difficile, including the c-di-GMP riboswitch
upstream of the flgB operon, appear to act through Rho-independent mechanisms [77, 78]. To
our knowledge, this is the first example of Rho-mediated transcription termination within a 5’
UTR that results in modulation of downstream gene expression in a gram-positive species.
In E. coli, Rho requires cofactors NusA and NusG to terminate transcription at many sites
[86]. NusG and NusA are essential for growth of C. difficile R20291 [53], but the cofactor
requirements for C. difficile Rho are currently unknown. Introduction of C. difficile rho into a
heterologous host B. subtilis did not alter the ability of C. difficile Rho to terminate transcrip-
tion of the flgOFF construct. These data suggest that either Rho is able to terminate flagellar
transcription without additional cofactors, or it is able to use homologs of NusA, NusG, or
other potential cofactors present in B. subtilis. Interestingly, while both C. difficile and B. subti-
lis encode Rho, only the C. difficile factor terminates flgOFF transcription. This difference
could be caused by a difference in structure of these two proteins. Although many of the fea-
tures of Rho are conserved across bacteria, in ~35% of species, including C. difficile, Rho con-
tains an N-terminal insertion domain (NID) whose length and composition are not conserved
among species [87]. In other bacterial species with an NID-containing Rho, the NID imparts
diverse functions [88–90]. It is therefore possible that the insertion domain of C. difficile Rho
confers the ability to terminate flgOFF transcription.
Mutations in rho negatively affect initial colonization in a mouse model of infection, result-
ing in a delay in colonization. We ruled out contributions from other phase-variable loci by
ensuring that MS5 and MS10 are isogenic with the parental strains at these sites. The rhomuta-
tions likely have pleiotropic effects that impact colonization [91, 92], however the delayed colo-
nization may be due in part to the defects in growth and sporulation of the motile suppressor
mutants. Interestingly, a high-throughput screen in C. difficile R20291 did not identify rho as a
gene required for sporulation [53]. How Rho affects growth and sporulation in C. difficile is
unknown, but may arise from pervasive transcription, particularly loss of suppression of anti-
sense transcription, or other potential consequences of loss of Rho [86, 93–95]. Further studies
are needed to elucidate the effects of Rho on global transcription in C. difficile to determine the
cause of the observed growth defects as well as other phenotypes affected by Rho.
Materials and methods
Growth and maintenance of bacterial strains
Strains and plasmids used in this study are listed in S3 Table. C. difficile was maintained in an
anaerobic chamber (Coy Laboratories) in an atmosphere of 85% N2, 5% CO2, and 10% H2. C.
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difficile and B. subtiliswere routinely cultivated in Brain Heart Infusion medium (Becton Dick-
inson) supplemented with 5% yeast extract (Becton Dickinson) (BHIS) at 37˚C. Where indi-
cated, bacteria were cultured in Tryptone Yeast (TY) broth. All C. difficile broth cultures were
grown statically, with 10 μg/mL thiamphenicol (Tm) for plasmid maintenance as needed. E.
coliDH5α and HB101(pRK24) were cultured under aerobic conditions at 37˚C in Luria-Ber-
tani (LB) broth. For selection of plasmids in E. coli, 100 μg/mL ampicillin (Amp) and/or 10 μg/
mL chloramphenicol (Cm) was used, as indicated. Kanamycin (Kan) 100 μg/mL was used to
select against E. coli after conjugations with C. difficile. Spectinomycin (Spec) 100 μg/mL was
used to select for B. subtilis transformants containing Cd-rho.
Soft agar swimming motility assay
Flagellum-dependent swimming motility was assayed in 0.5X BHIS-0.3% agar as previously
described [25]. When appropriate, Tm was added for plasmid maintenance, and 10 ng/mL
anhydrotetracycline (ATc) was added to induce gene expression. The diameter of motile
growth was measured after 24, 48, and 72 hours. Three independent experiments were per-
formed, each with six technical replicates. Images were taken using the G:BOX Chemi imaging
system with the Upper White Light illuminator.
Isolation and sequencing of motile suppressor mutants
The recV flgOFF mutants RT1693 and RT1694 (which contain the cwpV switch in the OFF or
ON orientation, respectively) were grown in BHIS broth until OD600 of 1, then 1.5 μL were
inoculated into 0.5X BHIS-0.3% agar motility medium and incubated at 37˚C for 48–96 hours.
Each plate included a non-motile sigD negative control (RT1566) and recV flgON (RT1702)
and recV flgOFF controls. Plates were examined for expansion of the recV flgOFF colonies,
which appeared in a subset of plates. Bacteria were collected from the outer edge of motile
growth and subcultured on BHIS agar.
Genomic DNA was extracted from seven motile isolates (RT1705 to RT1711 (MS 1–7), S3
Table) and the parental recV flgOFF strains (RT1693, RT1694) as previously described [96].
Genomic DNA of MS 1–7 was prepared using the KAPA HyperPrep Kit (Roche) and
sequenced using an Illumina HiSeq 2500 Rapid Run platform with paired ends and 100X cov-
erage by the UNC-CH High Throughput Genomic Sequencing Facility. The sequencing data
is available on the National Center for Biotechnology Information (NCBI) Sequence Read
Archive Database, accession number PRJNA630461. Sequencing reads were mapped to the
reference C. difficile R20291 genome (Accession No. FN545816.1) using CLC Genomics
Workbench v. 9 software (Qiagen), and nucleotide polymorphisms were identified using the
fixed ploidy variant detector function with default parameters. Whole genome sequencing was
not performed for MS 8–14. Instead, for MS 8–14 (RT1939-1945), the rho gene
(CDR20291_3324) was amplified by PCR with primers R2307 and R2308, and the products
were Sanger sequenced using primers R2307, R2308, R2366, and R2367. Primer sequences are
provided in S1 Table. Nucleotide polymorphisms were identified by alignment with the wild-
type sequence from R20291 using ClustalOmega [97].
Determination of invertible switch orientation by orientation-specific PCR
C. difficile was cultured from glycerol stocks on BHIS agar for 24 hours at 37˚C. A single col-
ony was suspended in 20 μL of dH2O and heated at 100˚C for 10 minutes. These lysates served
as templates for PCR using primers that discriminate between each flagellar switch sequence
orientation in R20291 (S1 Table). Primers R1614 and R857 were used to amplify the ON orien-
tation of the flagellar switch, which corresponds to the published sequence of R20291. Primers
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R1615 and R857 were used to amplify the OFF orientation of the flagellar switch. Similarly,
orientation-specific PCR was used to determine the orientations of the other invertible
sequences using primers listed in S1 Table, which follow the naming pattern LOCUS_pubF
and LOCUS_R for detection of the orientation in R20291 reference genome, and LOCUS_invF
and LOCUS_R for the inverse orientations. Three independent experiments were done.
Detection of FliC and TcdA by immunoblot
Western blots for TcdA and FliC production were performed as previously described [33, 34].
Cultures for TcdA immunoblotting were grown in TY broth overnight (~16 hours), diluted
1:50 in fresh TY broth, and grown until late stationary phase (OD600 of 1.8 to 2.0). Cultures for
immunoblotting FliC were grown overnight (~16 hours) in BHIS broth. For complementation
experiments, Tm was included in all growth media, and 10 ng/mL ATc was added to induce
gene expression. For both FliC and TcdA detection, samples were normalized to an OD600 1.0,
and then cells were collected by centrifugation at 16,000 x g for 5 minutes (TcdA) or 2,000 x g
for 10 minutes (FliC). Bacterial pellets were suspended in 1x SDS-PAGE sample buffer. The
lysates were separated on a 12% SDS-polyacrylamide gel for FliC detection or on an 8% SDS-
polyacrylamide gel for TcdA detection, then transferred to a nitrocellulose membrane (Bio-
Rad). Membranes were stained with Ponceau S (Sigma) to assess equal loading and imaged
using the G:Box Chemi imaging system. FliC was detected using α-FliC hamster sera (gener-
ous gift from Dr. Ghose-Paul) [34, 98] followed by goat anti-hamster IgG (H+L) secondary
antibody conjugated to DyLight 800 (Novus Biologicals). TcdA was detected using mouse α-
TcdA antibody (Novus Biologicals) followed by goat anti-mouse IgG secondary antibody con-
jugated to DyLight 800 4x PEG (Invitrogen). Blots were imaged using the Odyssey imaging
system (LI-COR), and quantification was performed with Image Studio Software. All strains
were assayed in at least three independent experiments.
Growth curves
Overnight cultures were diluted 1:50 into BHIS medium including 10 μg/mL Tm and 10 ng/
mL ATc as needed. Optical density (OD600) was measured every 30 minutes for 8 hours. Dou-
bling times were calculated based on the change in optical density during exponential growth.
Six biological replicates were assayed in two independent experiments.
Quantitative reverse transcriptase-PCR
Overnight cultures were diluted in BHIS medium containing thiamphenicol as needed. Cells
were grown to mid-exponential phase (OD600 0.8–1) or stationary phase (OD600~1.5) for anal-
ysis of flagellum (flgB, fliC) and toxin (tcdA, tcdB, tcdR) gene expression, respectively. RNA
was isolated as described previously [33, 96]. Briefly, cells were collected by centrifugation and
stored in ethanol:acetone (1:1) at -80˚C overnight. Cells were lysed by bead beating in cold Tri-
SURE (Bioline). Nucleic acids were extracted with chloroform, precipitated from the aqueous
phase with isopropanol, washed with ethanol, and suspended in RNase-free water. RNA was
treated with TURBO DNase (Thermo Fisher) according to the manufacturer’s protocol. Syn-
thesis of cDNA was done using the High-Capacity cDNA Reverse Transcription Kit (Applied
Biosystems) and random hexamers according to the manufacturer’s instructions. No-reverse
transcriptase controls were included in all experiments. Real-time PCR was performed using
10 ng of cDNA, a final primer concentration of 1 μM, and SYBR Green Real-Time qPCR
reagents (Bioline). Relative transcript abundance was calculated using the ΔΔCt method, with
rpoC as the control gene and the indicated reference condition/strain. Primers used are listed
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in S1 Table, with forward and reverse primers named according to the pattern gene-qF and–
qR, respectively.
Visualizing heterogeneity using fluorescent reporters
To visually examine population heterogeneity, we used a previously described protocol [99,
100]. Briefly, overnight cultures of strains containing the PflgM::mCherryOpt reporter were
diluted 1:100 into BHIS-Tm. Bacteria were grown anaerobically at 37˚C until OD600 ~0.5, 1
mL of culture was collected by centrifugation, and the remaining steps were performed aerobi-
cally. Cell pellets were washed with PBS, then suspended in 500 μl PBS and 120 μl 5x fixative
(20 μl NaPO4, pH 7.4; 100 μl 16% paraformaldehyde) [99]. The solution was incubated in the
dark at room temperature for 30 minutes followed by 30 minutes at 4˚C. After the fixative was
removed, cells were washed three times with PBS before suspension in 500 μl PBS and incuba-
tion overnight in the dark at 4˚C to allow for fluorophore maturation. Slides for microscopy
were prepared by placing 10 μl of concentrated culture onto a thin layer of 1% agarose applied
directly to the surface of the slide. Microscopy was performed using a 60x oil immersion
Nikon Plan Apo objective on a Keyence BZ-X810 equipped with Chroma 49005-UF1 for RFP
detection.
Generation of strains
To generate rho expression plasmids, wild-type and mutant rho alleles were amplified from
genomic DNA of recV flgOFF (RT1693) bacteria and 6 selected motile suppressors by PCR
using primers R2308 and R2307 [96]. PCR products were cloned via the EcoRV and BamHI
sites in pRT1611, a derivative of pRPF185 in which the gusA reporter gene was removed [33,
58]. After transformation into E. coliDH5α, Cm-resistant clones were recovered at 30˚C to
hinder additional mutations in rho. The presence of the rho insert and its sequence integrity
were confirmed using primers R2308, R2307, R2366, and R2367. The expression plasmids and
the pRT1611 control were introduced into C. difficile strains RT1693 (recV flgOFF), RT1702
(recV flgON), RT1709 (MS5), and RT1941 (MS10) via conjugation with E. coliHB101
(pRK24). The presence of the expected plasmid was confirmed by PCR with vector-specific
primers R1832 and R1833.
Plasmids containing transcriptional fusions of the phoZ alkaline phosphatase gene to flgB
and iterations of the upstream regulatory region were created previously [33]. These plasmids
were introduced into heat-shocked RT1693, RT1702, MS5, and MS10 [101]. For fluorescence
microscopy, pRT1676, a pDSW1728 derivative carrying PflgM::mCherryOpt [33], was intro-
duced into RT1693, RT1694, MS5, and MS10 by conjugation with E. coliHB101(pRK24) and
confirmed by PCR.
To introduce C. difficile rho (Cd-rho) into B. subtilis BS49, Cd-rho including its native ribo-
somal binding site (RBS) was amplified from R20291 genomic DNA by PCR using R2656 and
R2657, digested with HindIII and SphI, and ligated into similarly digested pDR111, which
allows for integration at the amyE site [102]. The resulting plasmid was transformed into B.
subtilis BS49 strains bearing previously described transcriptional fusions of phoZ to flgB and its
upstream regulatory region, and transformants were selected on LB-Spec agar.
Alkaline phosphatase assays
Overnight (~16 h) cultures of B. subtilis BS49 and C. difficile phoZ reporter strains were diluted
1:50 (C. difficile) or 1:100 (B. subtilis) into BHIS medium. Thiamphenicol was added to C. diffi-
cile growth media for plasmid maintenance. To induce expression of Cd-rho in B. subtilis, 0.5
mM isopropyl β-D-1-thiogalactopyranoside (IPTG) was added to the growth medium when
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cultures reached OD600 ~0.3. Controls without induction were processed in parallel. Where
indicated, bicyclomycin (Cayman Chemical) was used at 50 μg/mL. Mid-exponential phase
cells (OD600 0.8–1.3, 1 mL) were collected by centrifugation, the supernatant was discarded,
and pellets were stored at -20˚C overnight. Frozen pellets were thawed on ice, and the alkaline
phosphatase (AP) assay was performed as previously described [64].
Spore purification
Overnight cultures (100 μL) were plated on ten 70:30 agar plates [103]. After 72 hours of
growth at 37˚C, bacterial growth was scraped, suspended in 10 mL DPBS (Gibco) and kept at
room temperature overnight. Spores were purified by collection of the growth in DPBS, then
washing of the suspension four times with DPBS before purification using a sucrose gradient
as described [104]. After discarding supernatant containing cell debris, the spore pellet was
washed five more times with DPBS + 1% BSA. Spores were stored at room temperature until
use.
Germination assay
Spore germination was analyzed at room temperature (27˚C) by measuring the change in
OD600 [75]. Germination was carried out in clear 96-well flat bottom plates (Corning) in a
final volume of 100 μl and final concentration of 30 mM glycine, 50 mM Tris, 100 mM NaCl,
pH 7.5. Spores were heat-activated at 65˚C for 30 minutes, cooled on ice and suspended to a
final OD600 of 0.7. At the initiation of the experiment, 10 mM sodium taurocholate (Sigma
Aldrich) (TA) was added to induce germination; no-taurocholate controls were done in paral-
lel. Optical density at 600 nm was measured every 2 minutes for 1 hour using a BioTek Synergy
plate reader.
Sporulation assay
Sporulation assays were performed as described previously [74]. Briefly, C. difficile cultures
were grown overnight in BHIS broth supplemented with 0.1% TA and 0.2% fructose to pre-
vent spore accumulation. Cultures were diluted 1:30 in BHIS-0.1% TA-0.2% fructose, grown
to an OD600 of 0.5 and 250 μl of culture applied to 70:30 agar as a lawn [103]. A control ethanol
resistance sporulation assay was performed at this point to ensure no spores were present in
exponential phase cultures. After 24 hours of incubation at 37˚C, cells were suspended in
BHIS to an OD600 of 1.0, and an ethanol resistance sporulation assay was performed. A 0.5 ml
aliquot was mixed with 0.5 ml of 57% ethanol to achieve a final concentration of 28.5% etha-
nol, vortexed, and incubated for 15 minutes to eliminate all vegetative cells. Serial dilutions
were made in PBS-0.1% TA and plated on BHIS-0.1% TA agar for spore enumeration. Vegeta-
tive cells were enumerated by plating serial dilutions of the BHIS cell suspension on BHIS
agar. Sporulation efficiency was calculated as the total number of spores divided by the total
number of viable cells (spores plus vegetative).
Ethics statement
All animal studies were done in compliance with protocols approved by the UNC-CH Institu-
tional Animal Care and Use Committee.
Animal experiments
Groups of eight- to ten-week-old female and male C57BL/6 mice (Charles River) were given a
cocktail of antibiotics in their drinking water provided ab libitum for 3 days [105]. The
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antibiotic cocktail consisted of kanamycin (400 mg/L), gentamicin (35 mg/L), colistin
(850,000 units/L), vancomycin (45 mg/L), and metronidazole (215 mg/L) [105]. Four days
prior to inoculation, the mice were switched to regular water for the remainder of the experi-
ment. Clindamycin (10 μg/g body weight) was administered by intraperitoneal injection 48
hours prior to infection [14]. Mice were inoculated with 105 spores by oral gavage; control
mice received PBS only. Inoculums were quantified by plating serial dilution on BHIS-0.1%
TA agar and enumerating CFU. The animals were subsequently monitored for weight loss and
diarrheal disease. Fecal samples were collected in pre-weighed tubes every 24 hours for 9 days.
Fecal pellets were suspended in 1 mL DPBS and heated at 55˚C for 30 minutes. Serial dilutions
were plated on TCCFA to enumerate CFU per gram feces [14]. Two independent experiments
were done, each with 3 male and 3 female mice per C. difficile strain tested, for a total of 12
mice inoculated with each strain.
Supporting information
S1 Data. Single nucleotide polymorphisms identified in the MS1-7 and recV flg OFF strains
compared to the R20291 reference genome.
(XLS)
S1 Table. Oligonucleotides used in this study.
(DOCX)
S2 Table. Complete analysis of single nucleotide polymorphisms (SNPs) in MS1-7 and
recV flg OFF parent.
(DOCX)
S3 Table. Strains and plasmids used in this study.
(DOCX)
S1 Fig. recV flg OFF strains differ in status of cwpV switch. Orientation-specific PCR for the
cwpV switch in recV flgOFF strains RT1693 and RT1694. Band sizes– 469bp (OFF) or 322bp
(ON).
(TIF)
S2 Fig. All 14 motile suppressors have restored motility. Quantification of swimming motil-
ity assays for the 14 MS, RT1693 (recV flgOFF), and RT1702 (recV flgON). A non-motile sigD
mutant was included as a control. The means and standard deviation of four biological repli-
cates are shown.
(TIF)
S3 Fig. Motile suppressors have altered growth. Growth curves of MS1-14, recV flgON
(RT1702), the recV flgOFF parents (values combined for RT1694 (parent of MS1-7) and
RT1693 (parent of MS8-14)). Shown are the means and standard deviation for 3 biological rep-
licates.
(TIF)
S4 Fig. Expression of wild-type rho in MS5 and MS10 restores growth. Growth curves of
MS5 and MS10 expressing wild-type rho (pRho) or bearing vector. The recV flgOFF and recV
flgON strains carrying vector were included. Expression of rho was induced with 10 ng/mL
anhydrotetracycline (ATc). The means and standard deviation of three biological replicates
are shown.
(TIF)
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S5 Fig. Rho does not affect flagellar gene expression at the level of promoter. An alkaline
phosphatase (phoZ) reporter fusion to the flgB promoter (PflgB) and a promoterless:: phoZ con-
struct were introduced into recV flgON (RT1702), recV flgOFF (RT1693), MS5, and MS10.
The means and standard deviation of 5 biological replicates are shown.
(TIF)
S6 Fig. Supporting data for animal studies. (A) Orientation-specific PCR for the 6 additional
invertible sequences found in R20291, in recV flgOFF (RT1693), MS5, and MS10. WT R20291
was included as a control. Orientation is labelled as ON/OFF for the three invertible sequences
whose regulation has been studied (cwpV, flg, cmrRST) or as published (pub) or inverse (inv)
based on the R20291 reference genome for the Cdi2, Cdi3, and Cdi5 sequences whose effects
on gene expression are not known. (B) Antibiotic-treated male and female C57BL6 mice were
inoculated with 105 spores of the indicated C. difficile strain. CFU in feces collected every 24
hours post inoculation were enumerated as an indication of intestinal burden of C. difficile.
Shown are the full courses of infection for two independent experiments that each included 3
male and 3 female mice. The data are separated by motile suppressor and its respective parent
strain for clarity with the same data for wildtype R20291 in both upper and lower panels, with
means and standard deviation shown. Dotted line represents a limit of detection.
(TIF)
S7 Fig. Rho is dispensable for C. difficile spore germination. Purified spores of indicated
strains were germinated in the presence of taurocholate (+) or in buffer without germinant as
a control (-), and optical density (OD600) was measured. Germination was plotted as the ratio
of optical density (OD600) at a given time point (tx) versus initial OD600 (t0). A representative
germination plot of four independent experiments is shown.
(TIF)
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